Parth Unjiya

ChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “2‐(1‐Methyl‐1 H ‐indazol‐5‐yl)‐ N ‐arylisonicotinamide Analogs: Synthesis, Anticancer Screening, SAR and ADMET Studies”.

2‐(1‐Methyl‐1 H ‐indazol‐5‐yl)‐ N ‐arylisonicotinamide Analogs: Synthesis, Anticancer Screening, SAR and ADMET Studies

ChemistrySelect(2024)10.1002/slct.202400680

N/A

0DataRank · unranked

0 citations

Parth Unjiya, Ranjitsinh C. Dabhi, Hemal Parmar, Manish Shah, Umang P. Patel

2‐(3‐Iodo‐4‐Methylphenyl)‐4‐(aryl)oxazol‐5(4H)‐one Analogs: Synthesis, Anticancer Screening, SAR, in silico Molecular Docking, and ADMET Studies

ChemistrySelect(2025)10.1002/slct.202405244

N/A

0DataRank · unranked

1 citations

Parth Unjiya, Vaishali Rathod, Ranjitsinh C. Dabhi, Vidhi A. Trivedi, Manish K. Shah +1 more